Insider Transactions in Q2 2021 at Viracta Therapeutics, Inc. (VIRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 28
2021
|
Daniel R. Chevallard CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+17.45%
|
$0
$0.9 P/Share
|
|
May 11
2021
|
Lisa Rojkjaer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,750
+27.8%
|
$69,500
$2.42 P/Share
|